Stocks
PharmaCyte Biotech, Inc.PMCB
NASDAQHealthcareBiotechnology$0.34
Price as of · delayed, not real-time
A clinical-stage biotechnology company developing cell-based therapies for cancer, with a lead product candidate targeting pancreatic cancer. Its proprietary Cell-in-a-Box encapsulation technology is designed to protect implanted cells from immune rejection, a key differentiator in the oncology space. Investors track PMCB for its pipeline progress and potential regulatory milestones.
52W Range: $0.33-$1.51
Congressional Interest in PharmaCyte Biotech, Inc. (PMCB)
No congressional trades have been disclosed for PharmaCyte Biotech, Inc. (PMCB) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading PMCB?
No congressional trades found for this stock.